Skip to main content
. 2021 Mar 17;26(6):e1073–e1082. doi: 10.1002/onco.13716

Figure 2.

Figure 2

Use of NK1RA‐based antiemetic regimens in the acute phase of chemotherapy‐induced nausea and vomiting (day 1) for prophylaxis of HEC and carboplatin‐based therapy in the overall study population (n = 489,049). Abbreviations: AC, anthracycline‐cyclophosphamide; HEC, highly emetogenic chemotherapy; NK1RA, neurokinin‐1 receptor antagonist.